SuperGen, Inc. to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
DUBLIN, Calif., July 6 /PRNewswire-FirstCall/ -- SuperGen, Inc. today announced that Dr. Gregory Berk, Chief Medical Officer, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Thursday, July 12, 2007 at the Mandarin Oriental Hotel in New York City.
SuperGen's presentation at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference is scheduled to begin at 3:30 p.m. EDT. A live webcast of the presentation will be available on the Investor Relations section of the Company's Web site at http://www.supergen.com. The webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen SuperGen Timothy L. Enns Mary M. Vegh S.V.P., Corporate Communications Manager, Investor Relations & Business Development (925) 560-2845 (925) 560-0100 x111 mary.vegh@supergen.comtenns@supergen.com
SuperGen, Inc.CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment, +1-925-560-0100, Ext. 111, tenns@supergen.com, or Mary M.Vegh, Manager, Investor Relations, +1-925-560-2845, mary.vegh@supergen.com,both of SuperGen
Web site: http://www.supergen.com/